Skip to main content
OpenTrials

Clinical trial condition

Glioma

Explore clinical trials studying Glioma. Study availability and eligibility vary by location and protocol.

1,022 public trials 235 recruiting studies
Refine in advanced search Browse all conditions

Glioma trial results

Completed

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

NCT05199584

Conditions
Adenoma, Adenoma, Islet Cell, Brain Diseases, +52 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Zion, Illinois, United States
View all 16 locations
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

NCT04238819

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) Los Angeles, California, United States
  • Kaiser Permanente Oakland Oakland, California, United States
  • Kaiser Permanente Roseville Roseville, California, United States
View all 25 locations
View Trial Details
Completed

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

NCT03343197

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • United States, California Los Angeles, California, United States
  • United States, California San Francisco, California, United States
  • United States, Massachusetts Boston, Massachusetts, United States
  • United States, New York New York, United States
View Trial Details
Completed

Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation

NCT02481154

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • UCLA Oncology Center Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions